SynB1-ELP-P10 inhibits HCMV and MCMV growth at a lower IC50 due to increased cellular uptake, making it a suitable candidate to be used as an effective antiviral against CMV infection. The gene discussed is NR5A1; the disease is cytomegalovirus infection.